{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "CXE", "longName": "bioXXmed AG", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "marketState": "POSTPOST", "epsTrailingTwelveMonths": -0.33, "bookValue": 4.237, "fiftyDayAverage": 15.95, "fiftyDayAverageChange": 0.0, "fiftyDayAverageChangePercent": 0.0, "twoHundredDayAverage": 15.95, "twoHundredDayAverageChange": 0.0, "twoHundredDayAverageChangePercent": 0.0, "priceToBook": 3.764456, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "CytoTools AG", "nameChangeDate": "2023-05-11", "firstTradeDateMilliseconds": 1603263600000, "priceHint": 2, "regularMarketChangePercent": 0.0, "regularMarketPrice": 15.95, "regularMarketChange": 0.0, "regularMarketTime": 1683183868, "regularMarketPreviousClose": 15.95, "fullExchangeName": "Cboe UK", "financialCurrency": "EUR", "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "15.95 - 15.95", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "fiftyTwoWeekLow": 15.95, "fiftyTwoWeekHigh": 15.95, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "tradeable": false, "cryptoTradeable": false, "symbol": "T5OD.XC"}], "error": null}, "summary": {"result": [{"assetProfile": {"city": "Darmstadt", "zip": "64295", "country": "Germany", "website": "https://cytotools.de", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark-Andr\u00e9  Freyberg", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Dirk  Kaiser", "title": "Co-Founder & Chief Research Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}